Synonyms: | |
Status: | Phase 1 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | N06BX18 |
UNII: | 543512OBTC |
InChI Key | DDNCQMVWWZOMLN-IRLDBZIGSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C22H26N2O2 |
Molecular Weight | 350.46 |
AlogP | 4.15 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 0.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 34.47 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 26.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Hydrolase
|
- | - | - | - | 12 | |
Enzyme
Phosphodiesterase
Phosphodiesterase 1
Phosphodiesterase 1A
|
- | 18840 | - | 14000 | - | |
Enzyme
Phosphodiesterase
Phosphodiesterase 1
Phosphodiesterase 1B
|
- | 19000 | - | 14000 | - | |
Enzyme
Phosphodiesterase
Phosphodiesterase 1
Phosphodiesterase 1C
|
- | - | - | 14000 | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 39 | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 109 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Epilepsy | 1 | D004827 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 42971-09-5 |
ChEBI | 32297 |
ChEMBL | CHEMBL71752 |
DrugBank | DB12131 |
DrugCentral | 2828 |
EPA CompTox | DTXSID5023740 |
FDA SRS | 543512OBTC |
Guide to Pharmacology | 5285 |
PubChem | 443955 |
SureChEMBL | SCHEMBL50081 |
ZINC | ZINC000019796031 |